CarbonCure Technologies announced the appointment of Kristal Kaye as interim chief executive officer, following the resignation of founder Robert Niven. Kaye previously served as the company’s chief financial officer.
Niven will continue to serve on the company’s board of directors.
“Everyone at CarbonCure feels deep gratitude to Rob for his pioneering carbon utilization innovation for lower carbon concrete and his tireless dedication to CarbonCure over the past 13 years, with many years of research and development before that,” Kaye said. “Stepping into this interim role, I am eager to carry Rob’s legacy forward, and our entire team remains committed to that mission, our core values and the success of our concrete producer partners around the world.”
Under Niven’s leadership, CarbonCure developed and commercialized what it says is the most widely deployed carbon utilization solution for lower carbon concrete manufacturing. Over the past decade, CarbonCure has licensed hundreds of its carbon dioxide injection systems to producers across more than 24 countries, permanently mineralizing and reducing nearly 600,000 metric tons of CO2 while supplying 8.8 millions of truckloads of CarbonCure concrete.
